Loading clinical trials...
Loading clinical trials...
The TAG-SVD enrolled patients with clinical and neuroimaging features of cerebral small vessel disease (CSVD). All enrolled patients will receive next-generation sequence (NGS) with probes designed to...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Taiwan University Hospital
NCT06416371 · Cerebral Small Vessel Diseases, Lacunar Stroke, and more
NCT07342075 · Cerebral Small Vessel Diseases, Cognitive Impairment, and more
NCT03047369 · Leukodystrophy, White Matter Disease, and more
NCT04753970 · Cerebral Small Vessel Diseases, Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy, and more
NCT06164262 · Cerebral Small Vessel Diseases, Dementia, Mixed, and more
Department of Neurology, National Taiwan University Hospital
Taipei
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions